Role of indirect allorecognition in experimental late acute rejection

Transplantation

Volumn 64, Issue 12, 1997, Pages 1823-1828

  Vella, John P ^a   Vos, Lydia ^a   Carpenter, Charles B ^a   Sayegh, Mohamed H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CONFERENCE PAPER; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOPATHOGENESIS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOTOXICITY; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT;

AMINO ACID SEQUENCE; ANIMALS; CYCLOSPORINE; CYTOTOXICITY, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; GRAFT REJECTION; HEART TRANSPLANTATION; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MOLECULAR SEQUENCE DATA; PEPTIDES; RATS; RATS, INBRED LEW; RATS, INBRED WF; TIME FACTORS;

EID: 0031463266     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00033     Document Type: Conference Paper

References (29)

1. Sanders CE, Curtis JJ, Julian BA, et al. Tapering or discontinuing cyclosporine for financial reasons: a single-center experience. Am J Kidney Dis 1993; 21(1): 9.
2. De Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995; 59(3): 340.
3. Chavers BM, Matas AJ, Gillingham KJ, et al. Pediatric renal transplantation at the University of Minnesota: the cyclosporine years. Clin Transplant 1994; 1994(203): 203.
4. Roberti I, Reisman L, Lieberman KV, et al. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up). Clin Transplant 1994; 8(4): 405.
5. Hricik DE, O'Toole MA, Schulak JA, et al. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993; 4(6): 1300.
6. Wrenshall LE, Matas AJ, Canafax DM, et al. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone. Transplantation 1990; 50(2): 233.
7. Rao KV, Rose JK. Incidence, histological pattern, and clinical outcome of rejection episodes occurring in the late posttransplant period. Transplantation 1985; 40(6): 631.
8. Mittal R, Agarwal SK, Dash SC, et al. Clinical profile and course and outcome of late acute rejection episodes in living-related-donor renal allograft recipients. Nephron 1995; 71(1): 40.
9. Matas AJ, Gillingham KJ, Payne WD, et al. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994; 57(6): 857.
10. Shoskes AD, Wood JK. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15(1): 2.
11. Sayegh MH, Carpenter CB. Role of indirect allorecognition in allograft rejection. Int Rev Immunol 1996; 13: 221.
12. Benichou G, Takizawa AP, Olson AC, et al. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305.
13. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175(6): 1521.
14. Watschinger B, Gallon L, Carpenter CB, et al. Mechanisms of allo-recognition: recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57(4): 572.
15. Shirwan H, Learner M, Wang HK, et al. Peptides derived from the α helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Transplantation 1995; 59: 401.
16. Gallon L, Watschinger B, Murphy B, et al. The indirect pathway of allorecognition: the occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Transplantation 1995; 59(4): 612.
17. Sayegh MH, Khoury SJ, Hancock WW, et al. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Natl Acad Sci USA 1992; 89(16): 7762.
18. Akalin E, Hancock WW, Perico N, et al. Blocking cell microtubule assembly inhibits the alloimmune response in vitro and prolongs renal allograft survival by inhibition of Th1 and sparing of Th2 cell function in vivo. J Am Soc Nephrol 1995; 5(7): 1418.
19. Chen W, Murphy B, Waaga AM, et al. Mechanisms of indirect allorecognition in graft rejection: class II MHC allopeptide- specific T cell clones transfer delayed-type hypersensitivity responses in vivo. Transplantation 1996; 62(6): 705.
20. Hutchinson IF, Shadur CA, Duarte JS, et al. Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics. Transplantation 1981; 32(3): 210.
21. Mason DW, Morris PJ. Effector mechanisms in allograft rejection. Annu Rev Immunol 1986; 4: 119.
22. Liu Z, Sun YK, Xi YP, et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993; 177(6): 1643.
23. Vella JP, Ferreira M, Murphy B, et al. Indirect allorecognition of MHC allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64: 795.
24. Sherwood RA, Brent L, Rayfield LS. Presentation of alloantigens by host cells. Eur J Immunol 1986; 16(5): 569.
25. Benham AM, Sawyer GJ, Fabre JW. Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts. Transplantation 1995; 59(7): 1028.
26. Lee R, Grusby ML, Glimcher LH, et al. Indirect recognition by helper cells can induce donor specific cytotoxic T lymphocytes in vivo. J Exp Med 1994; 179: 865.
27. Steele DJ, Laufer TM, Smiley ST, et al. Two levels of help for B cell alloantibody production. J Exp Med 1996; 183(2): 699.
28. Liu Z, Colovai AI, Tugulea S, et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996; 98(5): 1150.
29. Connolly JM. The peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains. Proc Natl Acad Sci USA 1994; 91(24): 11482.